Cargando…

Risk of the Development of Diabetes and Cardiovascular Disease in Metabolically Healthy Obese People: The Korean Genome and Epidemiology Study

The reported effects of a metabolically healthy obese (MHO) phenotype on diabetes and cardiovascular disease (CVD) risk are contradictory. Within the context of a population-based cohort study, we aimed to investigate the long-term risk of an MHO status for the development of diabetes and CVD, and w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Nan Hee, Seo, Ji A, Cho, Hyunjoo, Seo, Ji Hye, Yu, Ji Hee, Yoo, Hye Jin, Kim, Sin Gon, Choi, Kyung Mook, Baik, Sei Hyun, Choi, Dong Seop, Shin, Chol, Cho, Nam Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839851/
https://www.ncbi.nlm.nih.gov/pubmed/27082607
http://dx.doi.org/10.1097/MD.0000000000003384
_version_ 1782428201488744448
author Kim, Nan Hee
Seo, Ji A
Cho, Hyunjoo
Seo, Ji Hye
Yu, Ji Hee
Yoo, Hye Jin
Kim, Sin Gon
Choi, Kyung Mook
Baik, Sei Hyun
Choi, Dong Seop
Shin, Chol
Cho, Nam Han
author_facet Kim, Nan Hee
Seo, Ji A
Cho, Hyunjoo
Seo, Ji Hye
Yu, Ji Hee
Yoo, Hye Jin
Kim, Sin Gon
Choi, Kyung Mook
Baik, Sei Hyun
Choi, Dong Seop
Shin, Chol
Cho, Nam Han
author_sort Kim, Nan Hee
collection PubMed
description The reported effects of a metabolically healthy obese (MHO) phenotype on diabetes and cardiovascular disease (CVD) risk are contradictory. Within the context of a population-based cohort study, we aimed to investigate the long-term risk of an MHO status for the development of diabetes and CVD, and whether consistency of this phenotype or age affected cardiometabolic outcomes. We recruited 7588 subjects without diabetes or CVD, aged 40 to 69 years at baseline examination, from the Korean Genome and Epidemiology Study, and followed-up these subjects for 10 years biennially. Participants were divided into 4 groups based on the body mass index and the presence of metabolic syndrome: metabolically healthy normal weight (MHNW), MHO, metabolically unhealthy normal weight (MUNW), and metabolically unhealthy obese (MUO). We defined persistent phenotypes if subjects maintained the same phenotype at every visit from baseline to their last visit. Incident diabetes and CVD morbidity or mortality were identified during 10 years of follow-up. Compared to MHNW controls, MUNW and MUO groups had increased risk for development of diabetes (hazard ratio [HR] 3.0 [95% CI: 2.5–3.6], and 4.0 [3.4–4.7], respectively) and CVD (HR 1.6 [1.3–2.0], and 1.9 [1.5–2.4], respectively). However, the MHO group showed only a marginal increase in risk for diabetes and CVD (HR 1.2 [0.99–1.6], 1.4 [0.99–1.8], respectively). The impact of MHO on the development of diabetes was more prominent in younger individuals (HR 1.9 [1.2–3.1] vs 1.1 [0.8–1.4], <45 years vs ≥45 years at baseline). Only 15.8% of MHO subjects maintained the MHO phenotype at every visit from baseline to the 5th biennial examination (persistent MHO). In subjects with persistent MHO, the risk for diabetes and CVD was significantly higher than those with persistent MHNW (1.9 [1.2–3.1], 2.1 [1.2–3.7], respectively). MHO phenotype, even if maintained for a long time, was associated with a significantly higher risk for the development of diabetes and CVD in Korean subjects.
format Online
Article
Text
id pubmed-4839851
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-48398512016-06-02 Risk of the Development of Diabetes and Cardiovascular Disease in Metabolically Healthy Obese People: The Korean Genome and Epidemiology Study Kim, Nan Hee Seo, Ji A Cho, Hyunjoo Seo, Ji Hye Yu, Ji Hee Yoo, Hye Jin Kim, Sin Gon Choi, Kyung Mook Baik, Sei Hyun Choi, Dong Seop Shin, Chol Cho, Nam Han Medicine (Baltimore) 4300 The reported effects of a metabolically healthy obese (MHO) phenotype on diabetes and cardiovascular disease (CVD) risk are contradictory. Within the context of a population-based cohort study, we aimed to investigate the long-term risk of an MHO status for the development of diabetes and CVD, and whether consistency of this phenotype or age affected cardiometabolic outcomes. We recruited 7588 subjects without diabetes or CVD, aged 40 to 69 years at baseline examination, from the Korean Genome and Epidemiology Study, and followed-up these subjects for 10 years biennially. Participants were divided into 4 groups based on the body mass index and the presence of metabolic syndrome: metabolically healthy normal weight (MHNW), MHO, metabolically unhealthy normal weight (MUNW), and metabolically unhealthy obese (MUO). We defined persistent phenotypes if subjects maintained the same phenotype at every visit from baseline to their last visit. Incident diabetes and CVD morbidity or mortality were identified during 10 years of follow-up. Compared to MHNW controls, MUNW and MUO groups had increased risk for development of diabetes (hazard ratio [HR] 3.0 [95% CI: 2.5–3.6], and 4.0 [3.4–4.7], respectively) and CVD (HR 1.6 [1.3–2.0], and 1.9 [1.5–2.4], respectively). However, the MHO group showed only a marginal increase in risk for diabetes and CVD (HR 1.2 [0.99–1.6], 1.4 [0.99–1.8], respectively). The impact of MHO on the development of diabetes was more prominent in younger individuals (HR 1.9 [1.2–3.1] vs 1.1 [0.8–1.4], <45 years vs ≥45 years at baseline). Only 15.8% of MHO subjects maintained the MHO phenotype at every visit from baseline to the 5th biennial examination (persistent MHO). In subjects with persistent MHO, the risk for diabetes and CVD was significantly higher than those with persistent MHNW (1.9 [1.2–3.1], 2.1 [1.2–3.7], respectively). MHO phenotype, even if maintained for a long time, was associated with a significantly higher risk for the development of diabetes and CVD in Korean subjects. Wolters Kluwer Health 2016-04-18 /pmc/articles/PMC4839851/ /pubmed/27082607 http://dx.doi.org/10.1097/MD.0000000000003384 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0, where it is permissible to download, share and reproduce the work in any medium, provided it is properly cited. The work cannot be changed in any way or used commercially. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle 4300
Kim, Nan Hee
Seo, Ji A
Cho, Hyunjoo
Seo, Ji Hye
Yu, Ji Hee
Yoo, Hye Jin
Kim, Sin Gon
Choi, Kyung Mook
Baik, Sei Hyun
Choi, Dong Seop
Shin, Chol
Cho, Nam Han
Risk of the Development of Diabetes and Cardiovascular Disease in Metabolically Healthy Obese People: The Korean Genome and Epidemiology Study
title Risk of the Development of Diabetes and Cardiovascular Disease in Metabolically Healthy Obese People: The Korean Genome and Epidemiology Study
title_full Risk of the Development of Diabetes and Cardiovascular Disease in Metabolically Healthy Obese People: The Korean Genome and Epidemiology Study
title_fullStr Risk of the Development of Diabetes and Cardiovascular Disease in Metabolically Healthy Obese People: The Korean Genome and Epidemiology Study
title_full_unstemmed Risk of the Development of Diabetes and Cardiovascular Disease in Metabolically Healthy Obese People: The Korean Genome and Epidemiology Study
title_short Risk of the Development of Diabetes and Cardiovascular Disease in Metabolically Healthy Obese People: The Korean Genome and Epidemiology Study
title_sort risk of the development of diabetes and cardiovascular disease in metabolically healthy obese people: the korean genome and epidemiology study
topic 4300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839851/
https://www.ncbi.nlm.nih.gov/pubmed/27082607
http://dx.doi.org/10.1097/MD.0000000000003384
work_keys_str_mv AT kimnanhee riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy
AT seojia riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy
AT chohyunjoo riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy
AT seojihye riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy
AT yujihee riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy
AT yoohyejin riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy
AT kimsingon riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy
AT choikyungmook riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy
AT baikseihyun riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy
AT choidongseop riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy
AT shinchol riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy
AT chonamhan riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy